During the last session, Compass Pathways Plc ADR (NASDAQ:CMPS)’s traded shares were 0.72 million, with the beta value of the company hitting 2.27. At the end of the trading day, the stock’s price was $4.41, reflecting an intraday loss of -0.90% or -$0.04. The 52-week high for the CMPS share is $12.75, that puts it down -189.12 from that peak though still a striking 8.16% gain since the share price plummeted to a 52-week low of $4.05. The company’s market capitalization is $301.73M, and the average intraday trading volume over the past 10 days was 1.2 million shares, and the average trade volume was 856.36K shares over the past three months.
Compass Pathways Plc ADR (CMPS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. CMPS has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.62.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Compass Pathways Plc ADR (NASDAQ:CMPS) trade information
Compass Pathways Plc ADR (CMPS) registered a -0.90% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.90% in intraday trading to $4.41, hitting a weekly high. The stock’s 5-day price performance is -12.50%, and it has moved by -31.42% in 30 days. Based on these gigs, the overall price performance for the year is -27.11%. The short interest in Compass Pathways Plc ADR (NASDAQ:CMPS) is 5.45 million shares and it means that shorts have 6.02 day(s) to cover.
The consensus price target of analysts on Wall Street is $23, which implies an increase of 80.83% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $23 and $23 respectively. As a result, CMPS is trading at a discount of -421.54% off the target high and -421.54% off the low.
Compass Pathways Plc ADR (CMPS) estimates and forecasts
Statistics show that Compass Pathways Plc ADR has underperformed its competitors in share price, compared to the industry in which it operates. Compass Pathways Plc ADR (CMPS) shares have gone down -41.04% during the last six months, with a year-to-date growth rate less than the industry average at -0.43% against 4.30. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -17.61% this quarter and then jump 2.73% in the quarter after that.
While earnings are projected to return -1.96% in 2024, the next five years will return 3.40% per annum.
CMPS Dividends
Compass Pathways Plc ADR is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Compass Pathways Plc ADR (NASDAQ:CMPS)’s Major holders
Compass Pathways Plc ADR insiders own 22.15% of total outstanding shares while institutional holders control 48.36%, with the float percentage being 62.12%. TCG CROSSOVER MANAGEMENT, LLC is the largest shareholder of the company, while 147.0 institutions own stock in it. As of 2024-06-30, the company held over 3.86 million shares (or 6.0073% of all shares), a total value of $23.3 million in shares.
The next largest institutional holding, with 3.67 million shares, is of CITADEL ADVISORS LLC’s that is approximately 5.7118% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $22.16 million.
Also, the Mutual Funds coming in first place with the largest holdings of Compass Pathways Plc ADR (CMPS) shares are ARK ETF Tr-ARK Genomic Revolution ETF and iShares Biotechnology ETF . Data provided on Oct 31, 2024 indicates that ARK ETF Tr-ARK Genomic Revolution ETF owns about 1.95 shares. This amounts to just over 2.84 percent of the company’s overall shares, with a $8.58 million market value. The same data shows that the other fund manager holds slightly less at 385.41, or about 0.56% of the stock, which is worth about $1.7 million.
